Skip to main content

Table 3 Specific HAV antibodies (mIU/mL) at the beginning (V1) and after 6 weeks (V3) of intervention

From: Evaluation of Lactobacillus coryniformis CECT5711 strain as a coadjuvant in a vaccination process: a randomised clinical trial in healthy adults

 

Control (n = 38)

PRO2 (n = 38)

PRO1 (n = 37)

P #

V1

Neg

Neg

Neg

–

V3

36.23 ± 16.45 a

41.61 ± 15.74 ab

50.54 ± 29.57 b

0.017

  1. Data are expressed as mean ± SD. #Differences among groups by one-way ANOVA (P < 0.05), also highlighted in bold. Different superscripts mean significant differences between visits; Bonferroni test (P < 0.05)
Back to article page

Nutrition & Metabolism

ISSN: 1743-7075

Contact us